Andrew Rasdal | Chief Executive Officer |
William Plovanic | Chief Financial Officer |
Rick Wise | Stifel |
Kyle Rose | Canaccord |
Ryan Zimmerman | BTIG |
Good day ladies and gentlemen and welcome to the Obalon Therapeutics’ Third Quarter 2017 Financial Results Call. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now turn the conference over to Bill Plovanic, Chief Financial Officer for Obalon.
You may begin.